1. Garbino J, Gerbase MW, Wunderil W, Deffenrnez C, Thomas Y, Rochat T, et al. Lower respiratory viral illness: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med. 2004. 170:1197–1203.

2. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised single-blinded interventional trial. Lancet. 2004. 363:600–607.

3. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicorb Agents Chemother. 2004. 48:2101–2107.

4. Marrie TJ, Wu L. Factors influencing in-hospital Mortality and community-acquired pneumonia: a prospective study of patients not initailly admitted to the ICU. Chest. 2005. 127:1260–1270.

5. Menedez R, Torres A, Zalaccin R, Aspa J, Martin-Villasclaras JJ, Borderias L, et al. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med. 2005. 172:757–762.

6. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005. 352:333–340.